Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (HK:2252) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shanghai MicroPort MedBot (Group) Co., Ltd. has executed a finance lease transaction involving its subsidiary, OrthoBot Suzhou, and Tianniuyan, where OrthoBot Suzhou sold Prototypes for RMB 60 million and leased them back for RMB 66 million over three years. This connected transaction is in compliance with the Listing Rules, requiring reporting and announcement but exempt from shareholder approval due to its size. The transaction was based on an independent valuation and is intended to support OrthoBot Suzhou’s R&D in orthopaedic navigation systems.
For further insights into HK:2252 stock, check out TipRanks’ Stock Analysis page.